# Client Finder / Client Intent Discovery — PDEF-4 Launch Criteria Completion Decision Preparation

**Record ID:** `CLIENT-FINDER-PDEF-4-LAUNCH-CRITERIA-COMPLETION-DECISION-PREPARATION-001`
**Date:** 2026-10-04
**Type:** read-only decision-preparation record. **Not a decision record. Not a Product Owner decision. Grants no
implementation, instrumentation, validation, deployment, release, or launch authority of any kind** (see §12).

---

## 1. Objective

PDEF-4 (launch criteria per tier) is recorded as **NOT DECIDED** in
`CLIENT_FINDER_PDEF_4_LAUNCH_CRITERIA_DECISION.md` — Q1–Q10 are all PENDING / UNDEFINED, with no Product Owner
input yet supplied. This record builds a precise, self-contained Product Owner questionnaire for Q1–Q10 so the
Product Owner can supply explicit answers in a future round, exactly as the PDEF-2/PDEF-3/entitlement-stacking
questionnaires were previously answered. It does not answer any question, does not select or imply any option,
and does not convert any analyst observation into a recommendation or decision.

## 2. Baseline (verified before writing this record)

| Item | Value |
|---|---|
| Branch | `feature/client-intent-discovery-complete` |
| HEAD | `af9ede93830f5e3e611195dc2451a470364def74` — unchanged |
| Staged files | 0 |
| Working tree before this record | 10 untracked files, including both existing PDEF-4 records (see §3) and the PDEF-2/PDEF-3/entitlement-stacking records this record incorporates as read-only context |
| Existing PDEF-4 completion/decision-amendment record | None found at `requirement/CLIENT_FINDER_PDEF_4_LAUNCH_CRITERIA_COMPLETION_DECISION_PREPARATION.md` or any equivalent path prior to this record |
| File created by this record | this file only |

## 3. Governing records consulted (hashes verified at baseline, unchanged by this record)

| Record | SHA-256 | Role |
|---|---|---|
| `requirement/CLIENT_FINDER_PDEF_4_LAUNCH_CRITERIA_DECISION_PREPARATION.md` | `5b54709269a16a75d3dc22394c102af5be77b4c55d1b66909a96375fab26d4ef` | Original Q1–Q10 preparation; question IDs, terminology, evidence, and analyst-proposal labels preserved and extended here. Not modified. |
| `requirement/CLIENT_FINDER_PDEF_4_LAUNCH_CRITERIA_DECISION.md` | `7e895893ca7bd774ff9314186d592dc76d30b701d4b17c3530e37f79a01e019e` | Confirms PDEF-4 remains NOT DECIDED; all Q1–Q10 PENDING / UNDEFINED as of this record. Not modified. |
| `requirement/CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md` | `5fd2f94c74e17ba6ed9fb11ea5a8db5bb38b6e451b0ebc4558e951dc269f8a7c` | Full PDEF-3 policy decision (PCG-1..6, cross-gate rule, definitions). Not modified, not reopened. |
| `requirement/CLIENT_FINDER_ENTITLEMENT_STACKING_DECISION.md` | `0333d2bc8805348bf789d7abba569611df561eb7ec4c6e8a9b076ff275b3acca` | ES-1/ES-5..ES-11 dual-tier decisions; ES-11 defers PCG-measurement treatment of dual-tier holders to PDEF-4 Q7/Q8. Not modified, not reopened. |
| `requirement/CLIENT_FINDER_PDEF_2_PRODUCT_DEFINITION_DECISION.md` | `0db621c09a619dcf81ca0cc20bd36148614e80e756b981ef8c9674a7023f16e8` | Tier/bundling/independent-purchase/credit-cap decisions. Not modified, not reopened. |
| `requirement/PROJECT_MASTER_CHECKLIST.md` | `15162827d7735bd18043430929024f5d48b2e8009610fe6f005c3d73e220e831` | §4.1 (PDEF-4 row), §4.2/§4.4 (T99-5, T499-4, T1499-4/5 blocked on PDEF-4), §9 (K1 completion gates PDEF-4 downstream). Not modified. |
| `requirement/MVP_SCOPE_BOUNDARY.md` §6.5 | not independently hashed (read-only reference) | Checked for PDEF-4/launch-criteria content — none found; billing/subscription-lifecycle scope boundary only, consistent with entitlement-stacking ES-9. Not modified. |
| `requirement/INDEPENDENT_KIT_PURCHASE_PRICING_REQUIREMENT.md` | not independently hashed (read-only reference) | Checked for PDEF-4/launch-criteria content — none found. Not modified. |

No other governing record was found to reference PDEF-4 beyond those listed above.

## 4. Current state confirmed

- PDEF-4 status per `CLIENT_FINDER_PDEF_4_LAUNCH_CRITERIA_DECISION.md` §1: **NOT DECIDED.**
- All of Q1–Q10 are **PENDING / UNDEFINED** in that record. No Product Owner answer has been supplied for any of
  them, in that task or in this one.
- The analyst proposals previously flagged (Q2, Q4, Q10) remain labeled **ANALYST PROPOSAL — NOT DECIDED** and are
  not adopted.
- PDEF-2 is DECIDED. PDEF-3 is DECIDED at the policy level (PCG-1..6 fully adopted). Entitlement stacking is
  DECIDED (ES-1, ES-5..ES-11). None of these three is reopened by this record.
- `PROJECT_MASTER_CHECKLIST.md` §4.1 records PDEF-4 as **NOT STARTED**, dependency "PDEF-2, PDEF-3," blocker
  "Depends on PDEF-2, PDEF-3." Both dependencies are now decided, but the checklist row itself is not updated by
  this record (a checklist update, if warranted, is a separate follow-up action, not performed here).

## 5. Separation preserved in this record

| Category | Where it appears below |
|---|---|
| Already-decided policy | §6 ("Current governing state" field of each question, and §10) |
| Unresolved Product Owner decisions | §7, each question's "Exact unresolved decision" and "Product Owner selection" fields |
| Analyst observations/proposals | §7, each question's "Analyst observation" field, explicitly labeled **NOT A RECOMMENDATION** |
| Engineering dependencies | §7, each question's "Dependencies/conflicts" field, and consolidated in §10 |
| Implementation authorization | §12 — explicitly none, for any question, regardless of how it is eventually answered |

## 6. Governing context (DECIDED elsewhere — not reopened, reproduced only as input to §7)

### 6.1 PDEF-2 (`CLIENT_FINDER_PDEF_2_PRODUCT_DEFINITION_DECISION.md`)

- Client Finder included in both ₹499 and ₹1,499; bundled into each tier's entitlement.
- ₹499 = Basic access; ₹1,499 = Advanced access.
- Either tier independently purchasable; no sequential-purchase requirement in either direction.
- ₹499 = 50 monthly lead-unlock credits; ₹1,499 = 300 monthly lead-unlock credits.

### 6.2 PDEF-3 (`CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md`)

- PCG-1 = 500 qualified visitors. PCG-2 = ≥ 50 buyers. PCG-3A = ≥ 10% (₹99→₹499). PCG-3B = ≥ 5% (independent
  ₹1,499 conversion). PCG-4 = ≥ 60% useful outcome. PCG-5 = ≤ 8% refund rate. PCG-6 = ≥ 70% completion.
- Measurement population for all gates is Client-Finder-specific.
- Default measurement window: rolling 30 days. PCG-5: rolling 30 days from purchase. PCG-6: rolling 30 days from
  first Client Finder activation.
- Cross-gate rule: where a gate applies to both tiers (PCG-2, PCG-4, PCG-5, PCG-6), the combined Client Finder
  population is the primary gate; per-tier results are reported as a diagnostic only. Tier-level diagnostic
  reporting does not itself create an additional pass/fail gate **"unless separately decided"** — that clause is
  exactly PDEF-4 Q8 (§7.8) and remains open.
- Definitions of "qualified visitor," "useful outcome," and "completion" are fixed at PDEF-3 §13 and are not
  restated or redefined here, to avoid drift; PDEF-4 answers must use them as given.

### 6.3 Entitlement stacking (`CLIENT_FINDER_ENTITLEMENT_STACKING_DECISION.md`)

- ES-1: ₹499 and ₹1,499 entitlements are cumulative/coexisting.
- ES-5/ES-6: ₹499 credits are not forfeited on ₹1,499 purchase; separate credit buckets.
- ES-7/ES-8: ₹1,499 Advanced access governs feature access when both are held; both credit allowances remain
  independently available (not pooled).
- ES-9: renewal/expiry/cancellation/downgrade out of MVP.
- ES-10: reverse purchase order (₹499 after ₹1,499) is permitted.
- ES-11: explicitly defers dual-tier PCG-measurement/launch-criteria treatment to PDEF-4 Q7/Q8; does not decide
  them. Any future PDEF-4 Q7/Q8 answer **must remain consistent with** the cumulative/coexisting,
  independently-purchasable, separate-bucket entitlement model decided by ES-1/ES-5..ES-10 and must not contradict
  it.

## 7. Product Owner questionnaire — Q1–Q10

Each question below gives: (1) current governing state; (2) evidence/source; (3) exact unresolved decision; (4)
clearly separated options; (5) analyst observation, where one exists, labeled **NOT A RECOMMENDATION**; (6)
dependencies/conflicts; (7) a blank Product Owner selection field. No option is pre-selected.

### 7.1 Q1 — Launch gate composition

| Field | Value |
|---|---|
| Current governing state | PENDING / UNDEFINED. PDEF-3 adopts PCG-1..6 independently with no stated all-or-subset launch rule. |
| Evidence | `CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md` §5–§12 (adopts each gate independently; no composition rule stated) |
| Exact unresolved decision | Must all of PCG-1..6 pass simultaneously before launch, or is a defined subset sufficient? If a subset, which gates are mandatory and which are advisory? |
| Options | (A) All applicable PCG-1..6 gates must pass; (B) a named subset is mandatory, remainder advisory — Product Owner must enumerate the subset; (C) gates are advisory only, none mandatory; (D) another explicitly defined composition |
| Analyst observation | None offered. |
| Dependencies/conflicts | Interacts with Q3 (whether gates are blockers at all) and Q4 (whether composition is evaluated per tier or jointly). |
| Product Owner selection | ____________________________ (select option and, if B, enumerate mandatory gates) |

### 7.2 Q2 — Minimum observation/cohort period

| Field | Value |
|---|---|
| Current governing state | PENDING / UNDEFINED. PDEF-3 fixes a rolling-30-day *measurement* window per gate but does not state how many such windows, or what elapsed time/sample size, must be observed before a launch decision can be made. Rolling 30 days is a measurement-window definition, not a mandatory 30-day pre-launch wait — the two must not be conflated. |
| Evidence | `CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md` §12 |
| Exact unresolved decision | What minimum observation/cohort period is required before the launch-gate evaluation may be used for a launch decision, and how does that period interact with the existing rolling-30-day measurement windows (e.g., is one closed rolling-30-day window sufficient, or must the window be observed for longer, or repeated)? |
| Options | (i) One full rolling-30-day window is sufficient once closed; (ii) a longer minimum period is required (Product Owner to specify, e.g., N consecutive windows or a fixed calendar period); (iii) no minimum period — evaluation may occur as soon as any window produces data, regardless of closure; (iv) another explicitly defined rule |
| Analyst observation | **NOT A RECOMMENDATION** — a single 30-day window may be sensitive to early-cohort noise, particularly for PCG-1/PCG-2, which require absolute counts (500 visitors, 50 buyers) that could be reached unevenly across a window. This is noted only because it may be relevant to the choice, not as a proposed answer. |
| Dependencies/conflicts | Interacts with Q5 (insufficient sample size) — a minimum-observation-period rule and a sample-insufficiency rule together determine when a gate becomes evaluable at all. |
| Product Owner selection | ____________________________ |

### 7.3 Q3 — Gate severity

| Field | Value |
|---|---|
| Current governing state | PENDING / UNDEFINED. `CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md` §16–§17 states PDEF-3 adopts the gates as commercial policy but does not itself decide their functional role in a launch decision. |
| Evidence | `CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md` §16, §17 |
| Exact unresolved decision | Are PCG-1..6 hard launch blockers, post-launch monitoring/optimization targets, or a mixture? If mixed, which specific gates are blockers and which are monitoring-only? |
| Options | (A) All six are hard launch blockers; (B) all six are monitoring/optimization targets only, none blocks launch; (C) a mixed assignment — Product Owner must specify each gate's status individually; (D) another explicitly defined rule |
| Analyst observation | None offered. |
| Dependencies/conflicts | Directly determines how Q1's composition rule functions in practice; also interacts with Q9 (initial launch vs. post-launch optimization). |
| Product Owner selection | ____________________________ (if C, list each of PCG-1..6 with its status) |

### 7.4 Q4 — Tier launch structure

| Field | Value |
|---|---|
| Current governing state | PENDING / UNDEFINED. PDEF-2 establishes independent purchasability of ₹499/₹1,499 as a commercial rule; entitlement stacking (ES-1) confirms the two entitlements can coexist; neither extends to a launch-sequencing rule. |
| Evidence | `CLIENT_FINDER_PDEF_2_PRODUCT_DEFINITION_DECISION.md` §10 (independent purchase, not launch sequencing); `CLIENT_FINDER_ENTITLEMENT_STACKING_DECISION.md` ES-1 (coexistence, not launch sequencing); `PROJECT_MASTER_CHECKLIST.md` §4.2/§4.4 (T99-5, T499-4, T1499-4/5 listed as separate tasks per tier with no stated ordering or joint-launch requirement) |
| Exact unresolved decision | Must ₹499 and ₹1,499 launch together, or may they launch independently (and, if independently, in what structure)? |
| Options | (A) Both tiers launch together; (B) ₹499 launches independently; (C) ₹1,499 launches independently; (D) another explicitly defined structure (e.g., a specific grouping or sequencing the Product Owner states) |
| Analyst observation | **NOT A RECOMMENDATION** — since PDEF-2 treats ₹499/₹1,499 as independently purchasable in both directions and entitlement stacking treats them as coexisting rather than sequential, independent per-tier launch may be structurally consistent with those existing decisions. This is an observation only and is not adopted. |
| Dependencies/conflicts | Must remain consistent with PDEF-2's independent-purchase rule and ES-1/ES-10's coexistence/reverse-order rules; must not be read as altering either. |
| Product Owner selection | ____________________________ |

### 7.5 Q5 — Insufficient sample size

| Field | Value |
|---|---|
| Current governing state | PENDING / UNDEFINED. No record states what happens if, e.g., fewer than 500 qualified visitors or 50 buyers are observed within the applicable measurement window. |
| Evidence | `CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md` §5–§11 (absolute-count thresholds for PCG-1/PCG-2 stated; no sample-insufficiency rule) |
| Exact unresolved decision | What is the explicit policy when the required sample is not reached within the measurement window — specifically for absolute-count gates such as PCG-1 (500 qualified visitors)? An explicit rule is required; "fail," "pass," or "wait" must not be assumed by default. |
| Options | (A) Launch is blocked pending sufficient sample (gate cannot be used to permit launch until the threshold is reached, regardless of elapsed time); (B) the gate remains formally unevaluated (neither pass nor fail) and does not by itself block or permit launch; (C) launch is allowed with a provisional/conditional status pending later re-evaluation once sample is sufficient; (D) another explicitly defined rule |
| Analyst observation | None offered. |
| Dependencies/conflicts | Interacts with Q2 (minimum observation period) and Q3 (whether the affected gate is a blocker at all). |
| Product Owner selection | ____________________________ |

### 7.6 Q6 — Late refunds

| Field | Value |
|---|---|
| Current governing state | PENDING / UNDEFINED. PDEF-3 fixes PCG-5 at ≤ 8% refunds over a rolling 30-day window measured from purchase, but does not state how a refund occurring after an initial launch-gate evaluation has already been made is treated. |
| Evidence | `CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md` §10, §12 |
| Exact unresolved decision | How are refunds occurring after an initial launch-gate evaluation (using PCG-5) treated — do they retroactively revise that evaluation, are they excluded because they fall outside the window that was actually evaluated, is the evaluation cohort frozen at evaluation time, or some other explicit rule? |
| Options | (A) Only refunds occurring inside the specific 30-day window that was evaluated count toward that evaluation; later refunds do not retroactively change it; (B) a later refund retroactively reopens/revises the already-closed evaluation; (C) the evaluation cohort is frozen at the time of evaluation and is never revised, but PCG-5 continues to be evaluated again on a rolling basis going forward; (D) another explicitly defined rule |
| Analyst observation | None offered. |
| Dependencies/conflicts | Relevant only to the extent PCG-5 is a launch blocker under Q3; otherwise may be moot for launch purposes (though still relevant to post-launch monitoring if Q3/Q9 assign PCG-5 a monitoring role). |
| Product Owner selection | ____________________________ |

### 7.7 Q7 — Dual-tier users

| Field | Value |
|---|---|
| Current governing state | PENDING / UNDEFINED. The PDEF-3 cross-gate rule states combined-population measurement with per-tier diagnostics; entitlement stacking (ES-1/ES-5..ES-10) establishes that ₹499 and ₹1,499 can coexist with separate credit buckets and Advanced access governing feature access — but no record states how a user holding both entitlements is counted for PCG measurement or launch decisions specifically. ES-11 explicitly names this question (and Q8) as the open dependency. |
| Evidence | `CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md` §12; `CLIENT_FINDER_ENTITLEMENT_STACKING_DECISION.md` ES-1, ES-7, ES-8, ES-11 |
| Exact unresolved decision | Exactly how is a user who holds both ₹499 and ₹1,499 counted for (a) the combined-population PCG measurement and (b) any per-tier diagnostic or launch decision — once in the combined pool only, in each tier's diagnostic bucket separately, or some other explicit rule? Any answer must remain consistent with the already-decided cumulative/coexisting, independently-purchasable, separate-bucket entitlement model (§6.3) and must not contradict it. |
| Options | (A) Counted once in the combined population regardless of how many tiers held, and not separately attributed to either tier's diagnostic; (B) counted once in the combined population, and additionally counted in each held tier's diagnostic bucket (double-counted for diagnostics only, not for the combined gate); (C) counted according to the higher tier held only (consistent with ES-7's "Advanced governs access"), for both combined and diagnostic purposes; (D) another explicitly defined rule |
| Analyst observation | None offered. |
| Dependencies/conflicts | Must not contradict ES-1 (coexistence), ES-7 (Advanced governs feature access), or ES-8 (both credit limits independently available). Directly feeds Q8 (per-tier diagnostics). |
| Product Owner selection | ____________________________ |

### 7.8 Q8 — Per-tier diagnostics

| Field | Value |
|---|---|
| Current governing state | DECIDED, as far as it goes, that diagnostics are not automatically a gate; UNDEFINED on the "unless separately decided" clause. `CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md` §12 states tier-level diagnostic reporting does not itself create an additional pass/fail gate "unless separately decided." That clause is this question and remains open. |
| Evidence | `CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md` §12, §15 item 3 ("explicitly left as a future decision, not decided here") |
| Exact unresolved decision | Can a poor per-tier diagnostic result block launch even when the combined primary gate passes? If so, under what explicit threshold or condition? |
| Options | (A) Diagnostics never block launch — informational only, regardless of how poor; (B) a diagnostic divergence can block launch, but only when it crosses an explicitly defined threshold (Product Owner must state the threshold and which diagnostic(s) it applies to); (C) a diagnostic must be "healthy" by some explicit qualitative standard as a precondition, without being formalized as a numeric pass/fail gate (Product Owner must state the standard); (D) another explicitly defined rule |
| Analyst observation | None offered. |
| Dependencies/conflicts | Depends on Q7's answer (how dual-tier users are attributed to per-tier diagnostics) to be operable. Interacts with Q1 (gate composition) if diagnostics are made mandatory. |
| Product Owner selection | ____________________________ |

### 7.9 Q9 — Initial launch vs. post-launch optimization

| Field | Value |
|---|---|
| Current governing state | PENDING / UNDEFINED. No record states whether PCG-1..6 are preconditions for a tier's first general-availability launch, or targets evaluated only after some initial/controlled launch has already occurred. |
| Evidence | `CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md` (silent on launch sequencing); `PROJECT_MASTER_CHECKLIST.md` §4.2 T99-5 ("QA / controlled launch") suggests a controlled-launch phase may already be contemplated as distinct from general availability, but this is not stated as governing for PDEF-4 |
| Exact unresolved decision | Do PCG-1..6 govern the initial (first general-availability) launch, post-launch optimization only, both, or some other explicitly defined lifecycle (e.g., gating a controlled/QA phase separately from general availability)? |
| Options | (A) Gates must be met before any general-availability launch, following an earlier controlled/QA phase that does not itself require gate-passage; (B) gates apply to general-availability launch only, with no separate controlled phase contemplated; (C) gates apply continuously — both as a precondition and as ongoing post-launch monitoring; (D) another explicitly defined lifecycle |
| Analyst observation | None offered. |
| Dependencies/conflicts | Directly interacts with Q3 (gate severity) — a "monitoring only" answer to Q3 for a given gate would make that gate's role under Q9 "post-launch optimization" for that gate specifically. |
| Product Owner selection | ____________________________ |

### 7.10 Q10 — Instrumentation prerequisite

| Field | Value |
|---|---|
| Current governing state | PENDING / UNDEFINED, flagged as a hard practical dependency. No PCG-1..6 gate can be evaluated without instrumentation to measure qualified visitors, buyers, conversions, refunds, useful-outcome reports, and completion events — none of which exists yet or is designed/authorized by PDEF-2 or PDEF-3. |
| Evidence | `CLIENT_FINDER_PDEF_3_COMPLETION_DECISION.md` §15 item 1 ("Instrumentation/analytics design needed to actually measure any of the above — explicitly out of scope"), §17 (grants no instrumentation authority); `PROJECT_MASTER_CHECKLIST.md` §4.2 T99-4 ("Instrumentation for proposed gate metrics," status SCOPE-DEPENDENT, "after PDEF-3") |
| Exact unresolved decision | Must instrumentation/analytics be (i) implemented, and separately (ii) independently validated, before any PCG gate can be evaluated for a launch decision — or is mere availability sufficient, or some other explicit condition? Instrumentation DESIGN (what is built) must be kept separate from instrumentation AUTHORIZATION (whether building it is approved) — this question decides only the policy sequencing, not whether instrumentation work is itself authorized. |
| Options | (A) PDEF-4 requires instrumentation to be implemented AND independently validated before any gate may be used to permit launch; (B) PDEF-4 requires instrumentation to be implemented, but independent validation is not a precondition; (C) PDEF-4 is decided at the policy level now, with instrumentation treated as separate downstream engineering work not gated by this decision at all; (D) another explicitly defined condition |
| Analyst observation | **NOT A RECOMMENDATION** — since no gate can be observed without instrumentation existing in some form, some sequencing decision on this point is likely unavoidable before any instrumentation-build task (e.g., T99-4) or any launch task (e.g., T99-5, T499-4, T1499-4/5) can proceed. This is noted as a practical observation only, not a proposed policy. |
| Dependencies/conflicts | This question decides sequencing/policy only; it does not itself authorize instrumentation implementation, analytics work, or any engineering task under any answer (see §12). |
| Product Owner selection | ____________________________ |

## 8. Additional dependencies identified from the governing records (not new policy)

The following dependencies were identified while reconciling the governing records for this questionnaire. None is
a new policy requirement; each is already implied by the cited record and is restated here only for completeness:

1. `PROJECT_MASTER_CHECKLIST.md` §4.2 lists **T99-4** ("Instrumentation for proposed gate metrics," status
   SCOPE-DEPENDENT) as a precondition to T99-5, independent of however Q10 is eventually answered — T99-4 is
   itself not authorized by this record or by any PDEF-4 answer.
2. `PROJECT_MASTER_CHECKLIST.md` §9 confirms K1's completion as implementation work does not itself supply launch
   criteria, deployment, or release authority (K1-10 remains NOT AUTHORIZED) — this is restated as context only;
   K1 is not reopened here.
3. `MVP_SCOPE_BOUNDARY.md` §6.5 and PRD V2.2 §R-30 (subscriptions FUTURE/NOT IMPLEMENTED) confirm ES-9's
   "OUT OF MVP" renewal/expiry/cancellation/downgrade position is consistent with the existing scope boundary —
   no PDEF-4 answer should be read as reopening that boundary.

No other undisclosed dependency was found in `MVP_SCOPE_BOUNDARY.md`, `INDEPENDENT_KIT_PURCHASE_PRICING_REQUIREMENT.md`,
or any other record checked in §3.

## 9. No-guessing rule (restated)

Every analyst observation in §7 is explicitly labeled **NOT A RECOMMENDATION** and is excluded from §10's "already
decided" summary. No option listed in §7 is pre-selected, implied, defaulted, or treated as adopted by virtue of
appearing in this questionnaire.

## 10. Summary — decided vs. undefined vs. analyst material

| Category | Items |
|---|---|
| **Already decided** (PDEF-2/PDEF-3/entitlement stacking — not reopened) | Tier structure, bundling, independent purchase, credit caps, coexistence (§6.1, §6.3); PCG-1..6 thresholds, populations, windows, definitions, cross-gate rule (§6.2) |
| **Still undefined** (PDEF-4 questions, §7) | Q1–Q10 — none inferred from common product practice; each PENDING / UNDEFINED pending explicit Product Owner input via the blank selection fields in §7 |
| **Analyst observations** (clearly separated, not policy) | Noted under Q2, Q4, and Q10 only, each labeled **NOT A RECOMMENDATION**; not silently added to any PDEF-4 content |
| **Engineering dependencies** (not decided, not authorized) | Instrumentation build/validation (Q10, §8 item 1), credit-ledger mechanics (undesigned per PDEF-2/entitlement-stacking), deployment/release authority (K1-10, §8 item 2) |

## 11. Relationship to the existing PDEF-4 decision record

This record supersedes nothing in `CLIENT_FINDER_PDEF_4_LAUNCH_CRITERIA_DECISION.md`; that record remains the
authoritative statement that PDEF-4 is NOT DECIDED and that Q1–Q10 are PENDING / UNDEFINED. This record only
prepares a more detailed questionnaire for the same ten questions, adding explicit option sets, analyst-observation
labeling, dependency notes, and blank selection fields, exactly as the PDEF-2/PDEF-3/entitlement-stacking
preparation records previously did for their respective questions. Once the Product Owner supplies answers using
this questionnaire, a future task must update or supersede `CLIENT_FINDER_PDEF_4_LAUNCH_CRITERIA_DECISION.md` with
those answers — not performed here.

## 12. No authorization statement

**This record grants no authorization of any kind.** It does not decide any PDEF-4 question; does not adopt,
imply, select, or recommend any launch-blocking rule, observation period, sample-size treatment, refund-window
treatment, dual-tier user treatment, diagnostic-escalation rule, launch-sequencing rule, or instrumentation-
sequencing rule; does not design or authorize instrumentation, analytics, billing, credit-ledger, deployment,
release, or production traffic; and does not modify PDEF-2, PDEF-3, entitlement stacking, the existing PDEF-4
preparation or decision records, the PRD, the catalog, `PROJECT_MASTER_CHECKLIST.md`, any K1 record, or any code,
test, schema, migration, configuration, or dependency. It is a read-only preparation record. It is not committed or
pushed. **No implementation, validation, deployment, release, or launch authority is granted by this record.**

**Next governance action:** Product Owner completes the blank selection fields in §7 for Q1–Q10, after which a
future task updates `CLIENT_FINDER_PDEF_4_LAUNCH_CRITERIA_DECISION.md` to reflect those explicit answers — followed,
only then, by any separate instrumentation-planning and deployment-authorization decisions, neither of which is
addressed or authorized here.
